Would anyone here volunteer to do this? The sample(s) could probably be used to analyze the 5AR Type 2 enzymes - to see if they’re still working, or are defect.
I’m sure the community will finance it.
I’ve been reading some more about dihydrofinasteride, and it worries me. Mostly because my experiments suggest that there is a problem with the conversion of testosterone to DHT - which leads to a severe problem with estrogen dominance. Propecia is obviously a steroidal drug, and the reductase enzymes converts finasteride to dihydrofinasteride. The result is an enzyme/NADP-dihydrofinasteride complex, and it has a half-life of 30 days in body temperature. The complex decomposes over time, and dihydrofinasteride appears to be the only thing that’s left. It sounds like finasteride is a suicide inhibitor - which means that the body has to produce new reductase enzymes. Now, the question is whether or not the body produces new enzymes at a constant rate, or if the enzymes which are damaged have to decompose before they’re replaced with new enzymes. The metabolism is individual, and maybe the process is a lot slower in those who develop PFS. If that’s the case, we should investigate compounds that are able to speed up the process, maybe by disrupting the membrane - as it’s referred to as a membrane-bound enzyme inhibitor complex.
What is known about dihydrofinasteride, btw? How does it affect the body?